Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Spero Therapeutics granted new employees an aggregate of 102,000 restricted stock unit awards and 67,600 stock options under its 2019 Inducement Equity Incentive Plan. The grants were made September 1, 2026 as inducements material to employment under Nasdaq Listing Rule 5635(c)(4); options vest 25% on September 1, 2027 with the remainder in 36 equal monthly installments, while RSUs vest in four equal annual installments beginning September 1, 2027.
Key figures
- Grant date
- September 1, 2026
- Rsu awards
- 102000
- Stock options
- 67600
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.